Legal & General Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-35,615
| Closed | -$963K | – | 3420 |
|
|
2024
Q2 | $963K | Buy |
35,615
+31,409
| +747% | +$653K | ﹤0.01% | 2215 |
|
|
2024
Q1 | $77.1K | Sell |
4,206
-2,226
| -35% | -$35.3K | ﹤0.01% | 2751 |
|
|
2023
Q4 | $78.9K | Sell |
6,432
-31,502
| -83% | -$295K | ﹤0.01% | 2769 |
|
|
2023
Q3 | $569K | Buy |
37,934
+2,798
| +8% | +$58.2K | ﹤0.01% | 2383 |
|
|
2023
Q2 | $1.14M | Buy |
35,136
+16,878
| +92% | +$616K | ﹤0.01% | 2162 |
|
|
2023
Q1 | $714K | Buy |
18,258
+2,119
| +13% | +$104K | ﹤0.01% | 2231 |
|
|
2022
Q4 | $853K | Buy |
16,139
+652
| +4% | +$31.8K | ﹤0.01% | 2188 |
|
|
2022
Q3 | $697K | Sell |
15,487
-3,128
| -17% | -$135K | ﹤0.01% | 2257 |
|
|
2022
Q2 | $677K | Buy |
18,615
+4,030
| +28% | +$146K | ﹤0.01% | 2277 |
|
|
2022
Q1 | $602K | Buy |
14,585
+20
| +0.1% | +$704 | ﹤0.01% | 2345 |
|
|
2021
Q4 | $621K | Buy |
14,565
+396
| +3% | +$19.8K | ﹤0.01% | 2350 |
|
|
2021
Q3 | $780K | Buy |
14,169
+6,327
| +81% | +$331K | ﹤0.01% | 2308 |
|
|
2021
Q2 | $375K | Buy |
7,842
+900
| +13% | +$45.9K | ﹤0.01% | 2393 |
|
|
2021
Q1 | $352K | Sell |
6,942
-245
| -3% | -$13.6K | ﹤0.01% | 2357 |
|
|
2020
Q4 | $452K | Sell |
7,187
-29
| -0.4% | -$1.8K | ﹤0.01% | 2281 |
|
|
2020
Q3 | $485K | Sell |
7,216
-1,533
| -18% | -$83.7K | ﹤0.01% | 2202 |
|
|
2020
Q2 | $367K | Buy |
8,749
+5,335
| +156% | +$205K | ﹤0.01% | 2234 |
|
|
2020
Q1 | $108K | Sell |
3,414
-726
| -18% | -$29.1K | ﹤0.01% | 2389 |
|
|
2019
Q4 | $167K | Buy |
4,140
+2,194
| +113% | +$76.8K | ﹤0.01% | 2440 |
|
|
2019
Q3 | $63K | Buy |
1,946
+791
| +68% | +$31.5K | ﹤0.01% | 2665 |
|
|
2019
Q2 | $56K | Buy |
+1,155
| New | +$49.1K | ﹤0.01% | 2725 |
|
Other funds holding SILK
Legal & General Group's SILK Position: Q3 2024 in Review
Legal & General Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 35,615 shares — an estimated $963K sold.
Legal & General Group first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $1.14M in Q2 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Legal & General Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Legal & General Group sold 35,615 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $963K.
- Legal & General Group first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
- Legal & General Group's Silk Road Medical, Inc. Common Stock position peaked at $1.14M in Q2 2023.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Legal & General Group's 13F filing for Q3 2024, filed 14 Nov 2024.